Author

I. Mandjes

Observed names: I M Mandjes, IA Mandjes, Mandjes, I.

Institution: The Netherlands Cancer Institute

Observed institution: The Netherlands Cancer Institute

OpenAlex ID: A5110271184

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.

1993 · M T Huizing, A C Keung, et al. · Journal of Clinical Oncology · 308

Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: A European Cancer Centre (ECC) trial

1995 · M.T. Huizing, J.B. Vermorken, et al. · Annals of Oncology · 69

A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission

1999 · S. Rodenhuis, R. de Wit, et al. · Annals of Oncology · 66

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa

1992 · S. Rodenhuis, J.W. Baars, et al. · Annals of Oncology · 46

421TiP OPTImaL: Optimisation of treatment for patients with low stage triple-negative breast cancer with high stromal tumor-infiltrating lymphocytes

2025 · A.L. Rolfes, G. Awada, et al. · Annals of Oncology · 1

3MO Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial

2025 · M. Opdam, N. Ultee, et al. · ESMO Open

LBA14 Intensified alkylating chemotherapy with autologous stem cell rescue (IACT) or conventional chemotherapy followed by olaparib (CCT-O) in stage III, HER2-negative, homologous recombination deficient (HRD) breast cancer (BC): Survival results of the randomized-controlled SUBITO trial

2024 · S. Linn, R.L. Seefat, et al. · Annals of Oncology

P3-14-17: Paclitaxel, Carboplatin, and Trastuzumab in a Neoadjuvant Regimen for HER2−Positive Breast Cancer: The TRAIN Study.

2011 · GS Sonke, IA Mandjes, et al. · Cancer Research

Works count: 9

Citation count: 491

H-index: 4

I10-index: 4